Lv7
5008 积分 2021-05-31 加入
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
9天前
已完结
Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database
11天前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
19天前
已完结
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
19天前
已关闭
Embracing more treatment choices for metastatic, recurrent, or persistent cervical cancer
23天前
已完结
Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report
25天前
已完结
Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 1
27天前
已完结
Cadonilimab is effective and safe in recurrent cervical cancer
28天前
已完结
Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysis
1个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
